Immunotherapy boosts responses in hormone receptor-positive breast cancers

Competing interests

Z.M. is on the advisory board for or consults for Gilead Sciences, Daiichi Sankyo, AstraZeneca, Lilly Medical, Merck, Pfizer and Novartis. K.A.G. is on the advisory board for or consults for Pfizer, Novartis, Astra Zeneca, Eli Lilly, Merck, Gilead Sciences, Celcuity and City of Hope.

Comments (0)

No login
gif